46.7400.00% ( 0.000 )
Delay Closed: Nov 16, 16:08:11Financials
H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: WUXI BIO(02269) the Revenue is 13.61 B (+24.83%), Beat estimate;the EBIT is 4.429 B (+41.43%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
13.61B24.83%
13.25B21.50%
+0.36B3.33%
EBITExceed expectations
4.43B41.43%
3.73B19.15%
+0.70B22.28%
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 25, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
